About Acute Lymphocytic Leukemia (ALL)
Acute lymphocytic leukemia (ALL) is a type of cancer that affects the bone marrow where blood cells are made. ALL causes the growth of immature lymphoid cells (white blood cells). In ALL, these immature cells accumulate in the bone marrow and replace healthy blood cells. The disease can originate from lymphoid cells that give rise to B cells, T cells, or both.
It is more common in children, accounting for approximately 25% of childhood cancers and 80% of all leukemias in children. However, it can also affect adults, although it is less common. Symptoms of ALL may include easy bruising or bleeding, weakness, fever, and pain. Treatment for ALL typically involves chemotherapy, which aims to destroy the leukemia cells and achieve remission. Early diagnosis is crucial for better treatment outcomes, especially in adults who may not respond as well to therapy as children do.
Acute Lymphocytic Leukemia (ALL) is a type of cancer that affects the bone marrow and blood. The causes of ALL involve chromosomal and genetic abnormalities that lead to abnormal production of immature lymphoid cells. The exact causes of these genetic changes are still being studied.
Non-modifiable risk factors of ALL (factors that a person cannot change or control) include:
- Age: ALL is more common in children, with peak incidence between 2-5 years old. However, it can also occur in adults.
- Genetic disorders: Certain genetic conditions, such as Down syndrome and Li-Fraumeni syndrome, can increase the risk of developing ALL.
- Family history: Having a family member with leukemia may increase the risk of developing ALL.
Modifiable risk factors for ALL (factors that a person can potentially change or control) include:
- Exposure to certain chemicals: Prolonged exposure to certain chemicals like benzene or pesticides may increase the risk.
- Radiation exposure: High levels of ionizing radiation, such as from previous cancer treatments or nuclear accidents, may increase the risk.
- Infections: Some studies suggest that certain viral infections may play a role in the development of ALL.
It's important to note that these modifiable risk factors are still being studied, and more research is needed to establish a clear link. If you have concerns about your risk for ALL, it's best to consult with your healthcare professional who can provide personalized advice based on your individual situation.
Common symptoms of ALL include:
- Paleness
- Fatigue
- Shortness of breath
- Unusual and frequent bleeding or bruising
- Fever
- Night sweats
- Loss of appetite
- Repeated infections
- Unexplained weight loss
- Weakness
- Dizziness
- Light-headedness
- Severe or frequent nosebleeds
- Bleeding gums or heavy menstrual bleeding
- Bone or joint pain
As ALL progresses, additional symptoms may occur, such as:
- Abdominal swelling due to the buildup of cancer cells in the liver and spleen.
- Swollen lymph nodes, appearing as lumps under the skin in areas like the underarms, neck, or groin.
- Other symptoms if leukemia spreads to other areas, such as the lungs or brain.
It's important to note that these symptoms can also be caused by other conditions, so it's essential to consult a healthcare professional for an accurate diagnosis.
To diagnose ALL, the following examinations, tests, and procedures are commonly performed:
- Physical exam and health history: The healthcare provider will conduct a thorough physical examination and ask about your medical history, including any symptoms or signs of disease.
- Complete blood count (CBC) with differential: This test involves drawing a blood sample to check the number and type of white blood cells, red blood cells, platelets, and the amount of hemoglobin in the red blood cells.
- Immunophenotyping: A laboratory test that uses a sample of your blood or bone marrow to differentiate types of leukemia.
- Polymerase chain reaction (PCR) test: This blood test analyzes the effectiveness of treatment by checking for specific genetic markers associated with ALL. It is usually repeated every 3 months for at least 2 years.
- Lymph node biopsy: A sample or an entire enlarged lymph node may be removed to determine if leukemia has spread.
To determine the stage or severity of ALL, additional examinations, tests, and procedures may include:
- Lumbar puncture: If there is a suspicion that leukemia has spread to the central nervous system, a small fluid sample is taken from the lower spine using a needle.
- Computed tomography (CT) scan: This imaging test helps doctors see if cancer has spread to internal organs.
- Chest X-ray: A chest X-ray can detect signs of swollen lymph nodes in the chest.
Additional examinations, tests or procedures may be performed based upon initial findings and individual factors. It is important to consult with healthcare professionals regarding a diagnostic approach that accounts for the individual situation.
The goals of treatment for ALL are to:
- Achieve remission (where ALL is undetectable)
- Prevent relapse (prevent ALL from coming back)
- Improve overall survival.
Here are the different types of treatment options and how they work to achieve these goals:
- Chemotherapy: This is the mainstay of treatment for ALL. It uses drugs to kill leukemia cells in the blood and bone marrow. Chemotherapy is usually given in two phases: induction (to achieve remission) and post-remission (to prevent relapse).
- Radiation therapy: This treatment uses high-energy beams to target and destroy leukemia cells. It is often used in combination with chemotherapy, particularly for ALL that has spread to the central nervous system (CNS).
- Stem cell transplant: Also known as a bone marrow transplant, this procedure replaces damaged or destroyed bone marrow with healthy stem cells. It can be used in high-risk or relapsed cases of ALL to improve outcomes.
- Targeted therapy: These drugs specifically target certain molecules or pathways involved in leukemia cell growth. They have less harm on normal cells compared to traditional chemotherapy.
- Central nervous system (CNS) prophylaxis: This therapy aims to prevent the spread of leukemia cells to the CNS. It involves intrathecal chemotherapy (administered into the cerebrospinal fluid) and sometimes cranial radiation therapy.
It's important to note that treatment recommendations may vary based on individual factors such as age, overall health, and genetic characteristics. Always consult with your healthcare professional for personalized advice.
Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Side effects can occur. Check with your health care professional or read the information provided with your medication for additional side effect information.